The Chief Executive Officer of COA Research and Manufacturing Limited Company, Prof Samuel Ato Duncan, has announced the launch of a new product line, which is expected to generate $50 million in revenue each year. The new product, an injectable medication, is currently under research and aims to combat viruses and treat cancer.
The company’s factory, which will produce the new product line, will be constructed in the Ashanti Region on a tract of land donated by Otumfuo Osei Tutu II, the King of the Asante Kingdom. Prof Ato Duncan made this announcement during Otumfuo’s historic visit to the company’s factory in Wusorkrom, Abura Asebu Kwamankese District, Central Region.
Prof Ato Duncan expressed his gratitude to Otumfuo for his support and confidence in the company’s vision. He praised the King’s patronage, which has been instrumental in the company’s success. “There is no way I will mention the success story of COA Research and Manufacturing Limited Company without Otumfuo. He has been a wonderful personality,” Prof Ato Duncan said.
During the visit, Prof Ato Duncan showcased the company’s existing products, including COA FX, COA Mixture, COA Plus, and COA Malaria Typhoid (MT) mixture. He also highlighted upcoming products, such as COA Capsules, COA Energy water, COA Balm, and COA Ointment.
The company’s management team, including the Board Chairman, Daasebre Kwebu Ewusi, 2nd Deputy CEO, Dr Grace Bimpong, and Administrator, Dr Nsiah Agyemang, received Otumfuo and his delegation.
The launch of the new product line is expected to boost Ghana’s economy and provide employment opportunities for the youth.
COA Research and Manufacturing Limited Company is committed to producing high-quality products that meet international standards.
